{
    "symbol": "AKYA",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-08 07:42:05",
    "content": " Akoya had a very strong start to 2022, highlighted by the full commercial launch of our new PhenoCycler-Fusion System, the industry's fastest and most powerful spatial biology solution on the market. As Brian highlighted, total revenue for the first quarter of 2022 was $16.9 million, as compared to $12.2 million in the first quarter of 2021, representing 38% growth. Product revenue, which includes instruments, reagents and software was $13.3 million, compared to $10 million in the prior year period, representing 34% growth."
}